Administrative Core

行政核心

基本信息

  • 批准号:
    10304667
  • 负责人:
  • 金额:
    $ 45.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-22 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Alcohol use, common among PLWH, plays an increasingly important role in the risk for and management of HIV-associated comorbidities. Unhealthy drinking can exacerbate two highly prevalent HIV-related comorbidities/co-occurring conditions, chronic pain and physical inactivity, which in turn, can intensify alcohol use and affect physical and mental function in PLWH. We propose the Boston Alcohol Research Collaboration on HIV/AIDS – Comorbidity Center (Boston ARCH CC) as an extension of our Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) cohort launched in 2011 and renewed in 2016 with funding from NIAAA. In Boston ARCH CC we target in randomized trials these two modifiable conditions, pain and physical inactivity, that have a critical impact on a variety of other HIV-related comorbidities. We will also support secondary analyses of the existing Boston ARCH cohort, and provide support and mentoring to trainees and investigators accessing the cohort. The Administrative Core will be responsible for the day-to-day management of the Boston ARCH CC and the operation of its components. In addition to the Administrative Core, Boston ARCH CC elements include two Research Project Components (clinical trials), and a Biostatistics and Data Management Core that leads our secondary analysis and training missions. The specific aims of the Administrative Core are to: 1) Provide a rich research environment for Boston ARCH CC investigators and trainees, and assure efficient progress of high-quality alcohol and HIV comorbidity/co- occurring condition science; 2) Centralize support for Research Project Component clinical trial implementation (e.g. Data Safety Monitoring, digital clinical trial recruitment and enrollment, ecological momentary assessments, alcohol biomarker tests), beyond what would be achievable by individual stand-alone projects; 3) Facilitate secondary data analysis, data sharing, and publication from analyses of Boston ARCH cohort data related to pain, physical inactivity, and physical and mental health function; 4) Offer resources and mentoring for early career investigators interested in engaging in alcohol and HIV research; 5) Engage in collaborative science within and beyond the Boston ARCH CC. The Administrative Core, with its scientific and administrative leadership and coordinated activities, will be essential for assuring that Boston ARCH CC achieves its goals to reduce alcohol and HIV-associated comorbidities.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD SAITZ其他文献

RICHARD SAITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD SAITZ', 18)}}的其他基金

Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
  • 批准号:
    8932640
  • 财政年份:
    2014
  • 资助金额:
    $ 45.17万
  • 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
  • 批准号:
    8693153
  • 财政年份:
    2014
  • 资助金额:
    $ 45.17万
  • 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
  • 批准号:
    9539171
  • 财政年份:
    2014
  • 资助金额:
    $ 45.17万
  • 项目类别:
Addressing Alcohol/HIV Consequences in Substance Dependence-Boston ARCH Cohort
解决酒精/艾滋病毒对物质依赖的影响 - 波士顿 ARCH 队列
  • 批准号:
    8967071
  • 财政年份:
    2014
  • 资助金额:
    $ 45.17万
  • 项目类别:
Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
医院口服纳曲酮与注射纳曲酮:治疗酒精中毒的效果比较
  • 批准号:
    9121362
  • 财政年份:
    2014
  • 资助金额:
    $ 45.17万
  • 项目类别:
Screening and Brief Intervention (SBI) Implementation and Sustainability
筛查和简短干预 (SBI) 的实施和可持续性
  • 批准号:
    8128126
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
解决酒精/艾滋病毒对药物依赖的后果 - 波士顿 ARCH 队列
  • 批准号:
    8334561
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
解决酒精/艾滋病毒对药物依赖的后果 - 波士顿 ARCH 队列
  • 批准号:
    8211194
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:
URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)
URBAN ARCH (5/5) 波士顿队列 - 酒精和 HIV 相关合并症和并发症:虚弱、功能障碍、跌倒和骨折(4F 研究)
  • 批准号:
    9545618
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
解决酒精/艾滋病毒对药物依赖的后果 - 波士顿 ARCH 队列
  • 批准号:
    8719878
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 45.17万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 45.17万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 45.17万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 45.17万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 45.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了